SynaptraBIO
Biotechnology Research • 
Australia • 1-10 Employees
Company overview
| Headquarters | Australia |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at SynaptraBIO
Janet Van Eersel
Co-Founder
About SynaptraBIO
SynaptraBIO is an Australian Biotechn start-up developing new treatments for Alzheimer’s disease and related neurological conditions, building on its AI-powered Drug Discovery platform.
$
SynaptraBIO revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
SynaptraBIO has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
SynaptraBIO has never raised funding before.
Germany
Italy
United States
Frequently asked questions
SynaptraBIO is located in AU.
SynaptraBIO was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
SynaptraBIO has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
